Economic Impact of Non-Adherence

The Cost of Inconsistent Use

Non-adherence to continuous glucose monitoring has significant economic implications for both individuals and the healthcare system.

Healthcare System Impact

Studies suggest non-adherence to diabetes management technologies costs the US healthcare system approximately $290 billion annually.

Patient-Level Consequences

When CGM use is inconsistent:

• Higher medical bills from preventable complications
• Increased emergency department visits
• More hospitalizations for hypo/hyperglycemic events
• Accelerated diabetes progression

The Adherence Advantage

Consistent CGM monitoring can:

• Reduce healthcare costs by up to 50% compared to non-users
• Prevent expensive acute events
• Slow or prevent costly chronic complications

Drivers of Non-Adherence

Common barriers include:

• Cost and insurance issues
• Skin irritation or discomfort
• Alarm fatigue
• Technology overwhelm
• Lack of education on benefits

Manufacturer Efforts

Companies like Dexcom and Medtronic actively work to drive user engagement and adherence through:

• Improved user experience
• Educational programs
• Gamification features
• Caregiver sharing options